Global Cell And Gene Therapy Supply Chain/Logistics Market
HealthcareServices

Cell And Gene Therapy Supply Chain/Logistics Market Outlook 2025 – Insights for Executive and Strategic Planning

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cell And Gene Therapy Supply Chain/Logistics Market Grown from 2024 to 2025?

In recent years, the market size for cell and gene therapy supply chain/logistics has seen a tremendous increase. It is forecasted to rise from $1.41 billion in 2024 to $1.58 billion in 2025, showcasing a compound annual growth rate (CAGR) of 11.8%. The historical growth of this market can be credited to several factors including an increase in chronic diseases prevalence, effective management of supply chain prerequisites, enhancement in upkeeping drug integrity, progressed regulatory frameworks, and a heightened focus on risk mitigation and compliance.

What Growth Rate Is Anticipated for the Cell And Gene Therapy Supply Chain/Logistics Market in the Coming Years?

The market for cell and gene therapy supply chain/logistics is predicted to grow significantly in the coming years, expanding to a size of $2.44 billion in 2029 at a compounded yearly growth rate of 11.5%. This expected expansion in the forecasted period can be ascribed to elements like the growth of personalized medicine, development of therapies without cells, an increase in chronic illnesses and the global cell therapy manufacturing market, and an effective management of supply chain demands. In addition to these, key trends in the forecast period such as escalating research and development spending, embracing cutting-edge technology, the introduction of favorable programs and initiatives to simplify access, and collaborations between cell and gene therapy firms, supply chain providers and logistics businesses, and the provision of custom services to support patient identification at any stage will also contribute to this growth.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp

Who Are the Leading Companies in the Cell And Gene Therapy Supply Chain/Logistics Market?

Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

What Are the Key Drivers of the Cell And Gene Therapy Supply Chain/Logistics Market?

The rise in demand for cell and gene therapies is fueling the growth of the supply chain or logistics market related to these treatments. These therapies represent advanced medical interventions that alter cells or genes to manage diseases, presenting potential advancements for conditions previously deemed untreatable. The suitable temperature and storage prerequisites required for these therapies can be maintained through supply chain and logistics services, which aid in everything from procurement to the distribution and storage of these therapies. For example, the American Society of Gene & Cell Therapy, a non-profit medical and scientific society based in the US, reported a 10% increase in Phase III clinical trials for gene therapies in Q3 2023, marking the first rise since Q3 2022. Consequently, the intensifying demand for cell and gene therapies is propelling the supply chain or logistics market associated with these treatments.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12631&type=smp

What Are the Key Market Segments in the Cell And Gene Therapy Supply Chain/Logistics Industry?

The cell and gene therapy supply chain/logistics market covered in this report is segmented –

1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System

2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution

3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components

4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up

5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

Subsegments:

1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools

2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)

3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization

4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting

5) By Logistics Management System: Route Optimization And Planning, Transportation Management

6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes

7) By Quality Management System: Compliance Tracking, Quality Assurance And Control

8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation

What Are the Latest Trends in the Cell And Gene Therapy Supply Chain/Logistics Market?

The adoption of advanced technological platforms is a significant trend emerging in the cell and gene therapy supply chain/logistics markets. Major businesses in this field are embracing these modern platforms to cement their market position. For example, in April 2023, AmerisourceBergen Corporation., renowned for specializing in cell and gene therapy supply chain logistics, unveiled the Cell and Gene Therapy (CGT) Integration Hub. Powered by the company’s groundbreaking customer relationship management (CRM) system, the CGT Integration Hub can be incorporated into biopharma platforms, enhancing the oversight of the development and delivery of cell and gene therapies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

What Are the Key Regional Markets in the Cell And Gene Therapy Supply Chain/Logistics Industry?

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12631

This Report Delivers Insight On:

1. How big is the cell and gene therapy supply chain/logistics market, and how is it changing globally?

2. Who are the major companies in the cell and gene therapy supply chain/logistics market, and how are they performing?

3. What are the key opportunities and risks in the cell and gene therapy supply chain/logistics market right now?

4. Which products or customer segments are growing the most in the cell and gene therapy supply chain/logistics market?

5. What factors are helping or slowing down the growth of the cell and gene therapy supply chain/logistics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model